DGCR8 and neoplasm: We found that the SUMO-site mutation of DGCR8-K707R inhibited the anchor-independent growth, xenograft tumor growth and tumor cell migration (Figure 6, Supplementary Figure S6), and SUMOylation of DGCR8 enhanced its affinity with pri-miRNA as well as the direct repression of target by pri-miRNA.